Documents

Briefs, oral arguments, agency decisions and the Federal Register.

5,436 results

0.20s

  • Determination of Regulatory Review Period for Purposes of Patent Extension; REVUFORJ

    Federal Register · Notice · Feb 26, 2026

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by August 25, 2026. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    91 FR 9624Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; YCANTH

    Federal Register · Notice · Sep 6, 2024

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by March 5, 2025. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    89 FR 72853Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; STEGLATRO

    Federal Register · Notice · Sep 6, 2024

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by March 5, 2025. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    89 FR 72851Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; OXBRYTA

    Federal Register · Notice · Jun 30, 2021

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by December 27, 2021. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    86 FR 34767Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; TURALIO

    Federal Register · Notice · Jun 23, 2021

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by December 20, 2021. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    86 FR 32950Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; MICRA TRANSCATHETER PACING SYSTEM

    Federal Register · Notice · Jan 11, 2018

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by July 10, 2018. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    83 FR 1370Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; PROACT ADJUSTABLE CONTINENCE THERAPY FOR MEN

    Federal Register · Notice · Jan 12, 2018

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by July 11, 2018. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    83 FR 1620Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; Inspire Upper Airway Stimulation System

    Federal Register · Notice · Oct 23, 2017

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by April 23, 2018. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    82 FR 49029Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; SAPIEN 3 TRANSCATHETER HEART VALVE

    Federal Register · Notice · Jan 30, 2018

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by July 30, 2018. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    83 FR 4224Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; HYMOVIS

    Federal Register · Notice · Feb 16, 2018

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by August 15, 2018. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    83 FR 7059Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; EDWARDS INTUITY ELITE AORTIC VALVE

    Federal Register · Notice · May 24, 2019

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by November 20, 2019. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    84 FR 24158Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; PREVYMIS, New Drug Application 209939

    Federal Register · Notice · Nov 14, 2022

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by May 15, 2023. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    87 FR 68177Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; Nuzyra Injection (New Drug Application 209817)

    Federal Register · Notice · Nov 30, 2023

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by May 28, 2024. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    88 FR 83550Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; ANGELMED GUARDIAN SYSTEM

    Federal Register · Notice · Nov 7, 2022

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by May 8, 2023. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    87 FR 67042Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; CINTEC PLUS CYTOLOGY

    Federal Register · Notice · Mar 23, 2023

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by September 19, 2023. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    88 FR 17579Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; BULKAMID URETHRAL BULKING SYSTEM

    Federal Register · Notice · Sep 13, 2022

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by March 13, 2023. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    87 FR 56062Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; VIVISTIM SYSTEM

    Federal Register · Notice · Feb 14, 2024

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by August 12, 2024. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    89 FR 11294Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; ORGAN CARE SYSTEM HEART

    Federal Register · Notice · Feb 14, 2024

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by August 12, 2024. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    89 FR 11301Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; PORTICO TRANSCATHETER AORTIC VALVE IMPLANT

    Federal Register · Notice · Feb 14, 2024

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by August 12, 2024. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    89 FR 11293Health and Human Services DepartmentFood and Drug Administration
  • Determination of Regulatory Review Period for Purposes of Patent Extension; ORGAN CARE SYSTEM LIVER

    Federal Register · Notice · Feb 14, 2024

    Furthermore, any interested person may petition FDA for a determination regarding whether the applicant for extension acted with due diligence during the regulatory review period by August 12, 2024. … Under these acts, a product's regulatory review period forms the basis for determining the amount of extension an applicant may receive.

    89 FR 11303Health and Human Services DepartmentFood and Drug Administration

Ask Donna what matters in the record.

She can read the source against your case and show you exactly where the answer came from.

Ask Donna

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.